Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human CCL25/TECK Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB334500
This item is not returnable.
View return policy
Description
CCL25/TECK Monoclonal specifically detects CCL25/TECK in Human samples. It is validated for Neutralization.Specifications
CCL25/TECK | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
C-C motif chemokine 25, chemokine (C-C motif) ligand 25, Chemokine TECK, Ck beta-15, Ckb15, SCYA25TECKvar, small inducible cytokine subfamily A (Cys-Cys), member 25, Small-inducible cytokine A25, TECK, TECKMGC150327, thymus expressed chemokine, Thymus-expressed chemokine | |
Mouse | |
Protein A or G purified from ascites | |
RUO | |
6370 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG2b |
Neutralization | |
52513 | |
Neutralization 3-12 ug/mL | |
AAB69981 | |
CCL25 | |
E. coli-derived recombinant human CCL25/TECK Gln24-Leu150 Accession # AAB69981 | |
500 μg | |
Primary | |
Detects human CCL25/TECK in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human CCL1, 2, 3, 4, 5, 7, 8, 11, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 26, recombinant mouse CCL1, 2, 3, 4, 5, 6, 7, 9/10/MIP-1 gamma , 11, 12, 17, 19, 21, 22, or recombinant rat CCL20. is observed. | |
Human | |
Ascites |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction